Mutational activation of BRAF confers sensitivity to transforming growth factor beta inhibitors in human cancer cells | ||
| dc.conicet.organizacion | University of Dundee | |
| dc.conicet.organizacion | The Beatson Institute for Cancer Research | |
| dc.conicet.organizacion | The Beatson Institute for Cancer Research | |
| dc.conicet.organizacion | MedImmune Limited | |
| dc.conicet.organizacion | Leiden University | |
| dc.conicet.organizacion | Leiden University | |
| dc.conicet.organizacion | University of Manchester | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental | |
| dc.conicet.organizacion | The Beatson Institute for Cancer Research | |
| dc.conicet.organizacion | University of Dundee | |
| dc.conicet.organizacion | University of Dundee | |
| dc.conicet.organizacion | The Beatson Institute for Cancer Research | |
| dc.conicet.organizacion | University of Manchester | |
| dc.conicet.organizacion | Universitat Zurich | |
| dc.conicet.organizacion | The Beatson Institute for Cancer Research | |
| dc.conicet.organizacion | The Beatson Institute for Cancer Research | |
| dc.conicet.organizacion | University of Edinburgh | |
| dc.conicet.organizacion | Leiden University | |
| dc.conicet.organizacion | University of Manchester | |
| dc.conicet.organizacion | The Beatson Institute for Cancer Research | |
| dc.conicet.organizacion | University of Dundee | |
| dc.contributor.author | Spender, Lindsay C. | |
| dc.contributor.author | Ferguson, John | |
| dc.contributor.author | Liu, Sijia | |
| dc.contributor.author | Cui, Chao | |
| dc.contributor.author | Girotti, Maria Romina | |
| dc.contributor.author | Sibbet, Gary | |
| dc.contributor.author | Higgs, Ellen | |
| dc.contributor.author | Shuttleworth, Morven K. | |
| dc.contributor.author | Hamilton, Tom | |
| dc.contributor.author | Lorigan, Paul | |
| dc.contributor.author | Weller, Michael | |
| dc.contributor.author | Vincent, David F. | |
| dc.contributor.author | Sansom, Owen J. | |
| dc.contributor.author | Frame, Margaret | |
| dc.contributor.author | Dijke, Peter ten | |
| dc.contributor.author | Marais, Richard | |
| dc.contributor.author | Inman, Gareth J. | |
| dc.date.issued | 2016-11-09 | |
| dc.description.abstract | Recent data implicate elevated transforming growth factor-β (TGFβ) signalling in BRAF inhibitor drug-resistance mechanisms, but the potential for targeting TGFβ signalling in cases of advanced melanoma has not been investigated. We show that mutant BRAFV600E confers an intrinsic dependence on TGFβ/TGFβ receptor 1 (TGFBR1) signalling for clonogenicity of murine melanocytes. Pharmacological inhibition of the TGFBR1 blocked the clonogenicity of human mutant BRAF melanoma cells through SMAD4-independent inhibition of mitosis, and also inhibited metastasis in xenografted zebrafish. When investigating the therapeutic potential of combining inhibitors of mutant BRAF and TGFBR1, we noted that unexpectedly, low-dose PLX-4720 (a vemurafenib analogue) promoted proliferation of drug-naïve melanoma cells. Pharmacological or pharmacogenetic inhibition of TGFBR1 blocked growth promotion and phosphorylation of SRC, which is frequently associated with vemurafenib-resistance mechanisms. Importantly, vemurafenib-resistant patient derived cells retained sensitivity to TGFBR1 inhibition, suggesting that TGFBR1 could be targeted therapeutically to combat the development of vemurafenib drug-resistance. | es |
| dc.description.fil | Fil: Spender, Lindsay C.. University of Dundee; Reino Unido. The Beatson Institute for Cancer Research; Reino Unido | |
| dc.description.fil | Fil: Ferguson, John. The Beatson Institute for Cancer Research; Reino Unido. MedImmune Limited; Reino Unido | |
| dc.description.fil | Fil: Liu, Sijia. Leiden University; Países Bajos | |
| dc.description.fil | Fil: Cui, Chao. Leiden University; Países Bajos | |
| dc.description.fil | Fil: Girotti, Maria Romina. University of Manchester; Reino Unido. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina | |
| dc.description.fil | Fil: Sibbet, Gary. The Beatson Institute for Cancer Research; Reino Unido | |
| dc.description.fil | Fil: Higgs, Ellen. University of Dundee; Reino Unido | |
| dc.description.fil | Fil: Shuttleworth, Morven K.. University of Dundee; Reino Unido | |
| dc.description.fil | Fil: Hamilton, Tom. The Beatson Institute for Cancer Research; Reino Unido | |
| dc.description.fil | Fil: Lorigan, Paul. University of Manchester; Reino Unido | |
| dc.description.fil | Fil: Weller, Michael. Universitat Zurich; Suiza | |
| dc.description.fil | Fil: Vincent, David F.. The Beatson Institute for Cancer Research; Reino Unido | |
| dc.description.fil | Fil: Sansom, Owen J.. The Beatson Institute for Cancer Research; Reino Unido | |
| dc.description.fil | Fil: Frame, Margaret. University of Edinburgh; Reino Unido | |
| dc.description.fil | Fil: Dijke, Peter ten. Leiden University; Países Bajos | |
| dc.description.fil | Fil: Marais, Richard. University of Manchester; Reino Unido | |
| dc.description.fil | Fil: Inman, Gareth J.. The Beatson Institute for Cancer Research; Reino Unido. University of Dundee; Reino Unido | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Spender, Lindsay C.; Ferguson, John; Liu, Sijia; Cui, Chao; Girotti, Maria Romina; et al.; Mutational activation of BRAF confers sensitivity to transforming growth factor beta inhibitors in human cancer cells; Impact journals; Oncotarget; 7; 50; 9-11-2016; 81995-82012 | es |
| dc.identifier.eissn | 1949-2553 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 1949-2553 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/24320 | |
| dc.journal.ciudad | Nueva York | es |
| dc.journal.number | 50 | es |
| dc.journal.pagination | 81995-82012 | es |
| dc.journal.pais | Estados Unidos | es |
| dc.journal.title | Oncotarget | es |
| dc.journal.volume | 7 | es |
| dc.language.iso | eng | es |
| dc.publisher | Impact journals | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5b%5d=13226 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.18632/oncotarget.13226 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347669/ | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/pmid/27835901 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by/2.5/ar/ | * |
| dc.subject | Melanoma | es |
| dc.subject | Resistance | es |
| dc.subject | Tgfb | es |
| dc.subject | Braf | es |
| dc.subject | Vemurafenib | es |
| dc.subject | Plx 4720 | es |
| dc.subject | Tgf Beta | es |
| dc.subject.classification | Bioquímica y Biología Molecular | es |
| dc.subject.classification | Ciencias Biológicas | es |
| dc.subject.classification | CIENCIAS NATURALES Y EXACTAS | es |
| dc.title | Mutational activation of BRAF confers sensitivity to transforming growth factor beta inhibitors in human cancer cells | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.62041b8d-a1ef-4fcc-9b4a-98b878690dc9_XX.pdf
- Tamaño:
- 3.97 MB
- Formato:
- Adobe Portable Document Format
- Descripción: